FDA takes steps to decrease barriers for overdose reversal agents with Dr. Marta Sokolowska Published 2024-03-21 Download video MP4 360p Download video MP4 720p Recommendations 1:23:58 Statistical Considerations for Premarketing Risk Assessment 1:12:24 Strategies to Increase Clinical Trial Participation for Diverse Communities: OMHHE REACH Consortium 7:00:43 185th Meeting of Vaccines and Related Biological Products Advisory Committee 01:33 Can Cardiac "Organ on a Chip" Technology Help Drug Toxicology Researchers? | Researching FDA 7:26:41 June 10, 2024 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee (PCNS) 7:42:03 REdI Annual Conference 2024: CBER (Biologics) Innovation in Medical Product Development (Day 2 of 2) 7:35:04 REdI Annual Conference 2024: CDER (Drugs) Innovation in Medical Product Development (Day 1 of 2) 5:48:02 REdI Annual Conference 2024: CDRH (Devices) Innovation in Medical Product Development (Day 1 of 2) 7:13:56 REdI Annual Conference 2024: CDER (Drugs) Innovation in Medical Product Development (Day 2 of 2) 00:26 Waterproof Sunscreen? Sun Safety Tips from Episode 5 of FDA In Your Day | Full Video on Channel 00:17 Can Cardiac "Organ on a Chip" Technology Help Drug Toxicology Researchers? (Full Video on Channel) 02:04 Opioid Use Disorder, New Biosimilar, Black Family Cancer Awareness Week, & more | In Your Day Ep. 6 01:48 The Future of Clinical Trials, The Real Cost Campaign, and Sun Safety Tips | FDA In Your Day Ep. 5 6:04:12 REdI Annual Conference 2024: CBER (Biologics) Innovation in Medical Product Development (Day 1 of 2) 05:28 Episode 5 - On The Road with Jim Jones - April 2024 6:52:20 REdI Annual Conference 2024: CDRH (Devices) Innovation in Medical Product Development (Day 2 of 2) 22:17 LACF and Acidified Foods Regulations and Requirements 7:33:16 May 24, 2024 Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC) Meeting 9:44:21 June 4, 2024 Meeting of the Psychopharmacologic Drugs Advisory Committee (PDAC) 2:26:13 Redesigned Pre-Submission Meetings in GDUFA III: Benefits for ANDA Submission and Approval Similar videos 12:13 FDA takes steps to decrease barriers for overdose reversal agents with Dr. Marta Sokolowska | Q&A wi 38:13 FDA Stakeholder Call - Expanding Access to Naloxone 4:16:21 Public Meeting: Patient-Focused Drug Development for Stimulant Use Disorder 3:33:42 Considerations for Buprenorphine Initiation and Maintenance Care (Day One) 2:15:32 Naloxone Access: Answering Questions Virtual Public Meeting March 29th, 2022 More results